Anzeige
Mehr »
Login
Mittwoch, 24.04.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Breaking News: InnoCan startet in eine neue Ära – FDA Zulassung!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESSWIRE
918 Leser
Artikel bewerten:
(2)

Art's-Way Manufacturing Co., Inc.: 8500 Square Foot Modular Cancer Research Facility Contract Announced by Art's Way Scientific

MONONA, IA / ACCESSWIRE / November 8, 2022 / Art's Way Manufacturing Co., Inc. (NASDAQ:ARTW), announces its wholly owned subsidiary, Art's Way Scientific, Inc., www.buildingsforscience.com, has executed a design contract for a 9 modular building unit, which will make up an 8,500 square foot research facility. The modular units are currently in design and are expected to be constructed in early 2023. The modular research facility is for one of the world's leading cancer treatment and research institutions.

Art's-Way Manufacturing Co., Inc., Monday, November 7, 2022, Press release picture

Mark Tschirgi, General Manager of Art's Way Scientific said, "We are honored to have the opportunity to participate in this significant project. We are serving as the modular building designer and builder on a multi-phased building renovation, upgrade, and new modular research space. We believe this high-profile project has the potential to open the doors to a lot of other opportunities."

The Art's Way Scientific design will integrate into their existing complex, increasing housing and procedural capacity. Being able to work within their restricted space requirements, installing equipment they already own, and walking in on day 1 using the same protocol across their research provides a seamless expansion. There is minimal site disruption and waste with a modular design compared to a traditional site-built option. Sections will be constructed off-site, delivered, and set in place on site.

David King, CEO and Chief Executive Officer, said, "We are grateful for the opportunity to participate in this project with this prestigious institution and valued client. As a result of this contract and other smaller contracts recently awarded to Scientific, our order backlog takes us into mid-2023."

About Art's Way Scientific, Inc. Buildings for Science

Art's Way Scientific, Inc. is a wholly owned subsidiary of Art's Way Manufacturing, Inc. It is the recognized leading supplier of modular laboratories for biocontainment, animal husbandry science, public health, and agricultural animal housing. Art's Way Scientific custom designs, manufactures, delivers, and installs modular laboratories and research facilities to meet customers' specific research requirements. For more information, visit our website at www.buildingsforscience.com.

CONTACT:
David King, CEO
712.208.8467 ext. 200
davidk@artsway.com
www.artsway.com

SOURCE: Art's Way Manufacturing, Inc.

View source version on accesswire.com:
https://www.accesswire.com/723886/8500-Square-Foot-Modular-Cancer-Research-Facility-Contract-Announced-by-Arts-Way-Scientific

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2022 ACCESSWIRE
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.